Nomogram Predicts Cancer-Specific Survival in Small-Bowel Adenocarcinoma

Development of a nomogram using SEER database data for small-bowel adenocarcinoma patients shows superior predictive performance in cancer-specific survival over traditional staging systems. Factors like sex, age, tumor characteristics, and treatment modalities significantly impact survival outcomes. Nomogram offers enhanced predictive accuracy and clinical utility, highlighting its potential for personalized treatment strategies and improved patient outcomes.